Fig 1 (425be71d 812e 4a54 8dea Bb27eb6b4ecf 01)
Yasmin
Product Images NDC 76413-130
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Yasmin (NDC 76413-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Central Texas Community Health Centers, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (425be71d 812e 4a54 8dea Bb27eb6b4ecf 02)
This appears to be a chart displaying the risk of blood clots for women based on their pregnancy status and use of CoC (contraceptive pills) over a period of 10,000 women years. The chart shows that non-pregnant non-COC users have the lowest risk of blood clots, while postpartum women (up to 12 weeks after delivery) and CoC users have a higher risk. The data is based on reference studies and actual pregnancy duration.*
Structural Formulas (425be71d 812e 4a54 8dea Bb27eb6b4ecf 03)
Drospirenone Ethinyl estradiol is a combination of two female hormones used for oral contraception.*
Pregnancy Diagram (425be71d 812e 4a54 8dea Bb27eb6b4ecf 04)
This text describes different methods of birth control and their effectiveness. It provides statistics on the number of pregnancies per 100 women for various levels of contraception. The text mentions several methods such as pills, injections, devices, and sterilization. It also mentions choices like no sex, withdrawal, and the use of spermicide.*
Pill Pack Image (425be71d 812e 4a54 8dea Bb27eb6b4ecf 05)
Blood Clot Diagram (425be71d 812e 4a54 8dea Bb27eb6b4ecf 06)
This appears to be a chart or graph showing the number of women with a blood clot out of 10,000 women years (WY), for different categories including non-COC users, pregnant women and postpartum women (up to 12 weeks). The data for pregnancy is based on actual duration of pregnancy in reference studies and assumes a pregnancy duration of nine months. The chart also indicates that the rate of blood clotting is 7 to 27 per 10,000 WY for pregnant women. There is also mention of non-pregnant and non-COC (contraceptive oral contraceptive) users but no additional information is provided.*
50419 0402 01 Splimage30 B8195c0a
50419 0402 01 Splimage30 Bb195dea
Principal Display Panel (Kit Carton Label)
This text is a prescription for Yasmin birth control pills. It provides instructions for taking one tablet daily and includes the product's NDC number, batch, and expiration date. The text also warns against transferring the drug to anyone other than the patient it was prescribed for due to federal law.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
